Cite
HARVARD Citation
Kang, D. et al. (n.d.). Novel fused pyrimidine and isoquinoline derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2016105532A1, WO2016105534A1 and WO2016105564A1. Expert opinion on therapeutic patents. pp. 383-391. [Online].